Schedule of Computation of Net Income (Loss) per Share |
The computation of loss per share and weighted average shares of the Company’s common stock outstanding for the periods presented are as follows (in thousands, except share and per share data): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | For the Three Months Ended September 30, | | For the Nine Months Ended September 30, | | | | | | 2022 | | 2021 | | 2022 | | 2021 | Numerator: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net loss attributable to common stockholders—basic and diluted | | | | | $ | (60,010) | | | $ | (130,193) | | | $ | (92,424) | | | $ | (197,562) | | | | | | | | | | | | | | Denominator: | | | | | | | | | | | | Weighted average common shares outstanding—basic and diluted | | | | | 97,100,453 | | | 85,463,755 | | | 96,245,149 | | | 48,214,724 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net loss per share: | | | | | | | | | | | | Basic and diluted net loss per share | | | | | $ | (0.62) | | | $ | (1.52) | | | $ | (0.96) | | | $ | (4.10) | | | | | | | | | | | | | | | | | | | | | | | | | | Anti-dilutive securities excluded from diluted loss per share: | | | | | | | | | | | | Stock options to purchase common stock | | | | | 1,534,949 | | | 254,965 | | | 849,061 | | | 254,965 | | Stock warrants | | | | | 163,508 | | | — | | | 108,951 | | | — | | Unvested restricted stock awards | | | | | 341,880 | | | 104,512 | | | 201,778 | | | 104,512 | | Unvested restricted stock units | | | | | 2,154,921 | | | 1,068,750 | | | 1,539,234 | | | 1,068,750 | | | | | | | | | | | | | | Total | | | | | 4,195,258 | | | 1,428,227 | | | 2,699,024 | | | 1,428,227 | |
|